Curfews to stay until end of September, says CCSA

Curfews to stay until end of September, says CCSA

The curfew imposed from 9pm–4am to curb coronavirus infections in some provinces, will remain in place until the end of this month at least, the Centre for Covid-19 Situation Administration (CCSA) has announced.

Taweesilp Visanuyothin, spokesman for the CCSA, yesterday said a CCSA meeting chaired by Prime Minister Prayut Chan-o-cha agreed to maintain the current restrictions, including curfew hours imposed in dark-red provinces, until the end of this month.

He said the CCSA also decided to make no status changes to provinces designated as dark-red (29), red (37) and orange (11) Covid-19 control zones until the end of this month.

"The Covid-19 situation has been assessed and it is agreed that the curfew will remain in place until the end of this month while the Covid-free set of measures and antigen tests will be carried out to keep infections and fatalities low in October," Dr Taweesilp said.

He also said the CCSA discussed the kingdom's upcoming vaccination drive on Sept 27–Oct 31, which will see the distribution of 24 million Covid-19 vaccine doses to five target groups.

Of the total jabs, 10 million doses are from AstraZeneca, 8 million from Pfizer and 6 million from Sinovac.

According to Dr Taweesilp, adults over the age of 18 will either receive a mixed dose of vaccines or two doses of the AstraZeneca vaccine.

As for the cross-vaccination programme, people will receive either Sinovac-AstraZeneca shots or AstraZeneca-Pfizer shots.

The vaccine doses that will be used for this group account for 70%, or 16.8 million, of the total 24 million doses.

Students aged 12-17 will receive two Pfizer doses, accounting for 20%, or 4.8 million, of the 24 million total vaccine doses.

Dr Taweesilp said the CCSA has made it clear that inoculations for this group will be on a voluntary basis and parents will be informed of all possible side effects like myocarditis.

Workers under the kingdom's social security system will receive Sinovac-AstraZeneca doses.

Do you like the content of this article?
COMMENT (1)